|
|
|
| Home Page > Division of Internal Medicine> Endocrinology, Metabolism, and Hypertension - Institute > Diabetes-Unit |
 |
List of Publications |
 |
|
| |
1. Ravid M, Greenman Y, Shapira J, Kedar I.
A non invasive screening of systemic reactive (secondary) amyloidosis, based on reduced amyloid degrading activity of amyloidotic serum.
Isr J Med Sci. 26:191-194;1990.
2. Greenman Y, Melmed S.
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab. 78:398-403;1994.
3. Greenman Y, Melmed S.
Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.
J Clin Endocrinol Metab. 79:724-729;1994.
4. Greenman Y, Prager D, Melmed S.
The IGF-1 receptor submembrane domain is intact in GH-secreting pituitary tumors. Clin Endocrinol. 42:169-172;1995.
5. Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N.
Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas.
J Clin Endocrinol Metab. 80:1577-1583;1995.
6. Greenman Y, Melmed S. Expression of somatostatin receptor subtype 1 gene transfected in human breast cancer cells and rat pituitary cells. J of Investigative Medicine. 43:161A;1995.
7 Greenman Y, Melmed S.
Thyrotropin-secreting pituitary tumors.
In: Melmed S, ed. The pituitary. Cambridge, Massachusetts: Blackwell Science, Inc; 546-558; 1995.
8. Tordjman K, Jaffe A, Greenman Y, Stern N.
Comments on the comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease (letter).
J Clin Endocrinol Metabol; 83:4530;1998.
9. Greenman Y, Woolf P, Coniglio J, O'Mara R, Pei L, Said JW, Melmed S
Remission of acromegaly caused by pituitary carcinoma after surgical excision of GH-secreting metastasis detected by 111-indium pentetreotide scan.
J Clin Endocrinol Metab. 81:1628-1633;1996.
10. Greenman Y, Melmed S.
Diagnosis and medical management of nonfunctioning pituitary tumors.
Annu Rev Med. 47:95-106;1996
11. Greenman Y, Melmed S.
Somatostatin receptor subtypes in pituitary tumors.
In: Melmed S, ed. Oncogenesis and Molecular Biology of Pituitary Tumors.
Frontiers of Hormone Research; 20:99-107;1996.
12. Ouaknine G, Razon N, Avram J, Liberchuk I, Veshchev I, Rochkind S, Ayalon D, Reider-Grosswasser I, Jossipov J, Stern N, Greenman Y, Tordjman K. The one nostril transnasal transphenoidal extramucosal approach: 324 cases. Proceedings of the 11th International Congress of Neurological Surgery. 557-561, 1997.
13. Ouaknine G, Razon N, Avram J, Veshchev I, Rochkind S, Ayalon D, Reider-Grosswasser I, Jossipov J, Stern N, Greenman Y, Tordjman K. Programmable classification of pituitary tumors. Proceedings of the 11th International Congress of Neurological Surgery. 547-550, 1997.
14. Greenman Y, Tordjman K, Stern N.
Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
Clin Endocrinol. 48:547-553;1998.
15. Greenman Y, Tordjman K, Somjen D, Reider-Grosswasser I, Kohen F, Ouaknine G, Stern N.
The use of b-subunits of gonadotropin hormones in the follow up of clinically non-functioning pituitary tumors.
Clin Endocrinology, 49:185-190;1998.
16. Somjen D, Tordjman K, Greenman Y, Kohen F, Ouaknine G, Stern N.
TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.
J Endocrinol Invest, 22:104-108; 1999.
17. Greenman Y, Trostanetsky Y, Sömjen D, Tordjman K, Kohen F, Stern N.
Effect of TRH on b-gonadotropin subunits in patients with pituitary microincidentalomas.
Eur J Endocrinology, 141:17-21;1999.
18. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N.
The low dose (1mg) adrenocorticotropin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function:sensitivity, specificity and accuracy in comparison with the high dose (250 mg) test.
Clin Endocrinol, 52:633-640;2000.
19. Stefaneanu L, Kovacs K, Thapar K, Horvath E, Melmed S, Greenman Y,
Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas.
Endocrine Pathol. 11: 41-48; 2000.
20. Stern N, Grosskopf I, Shapira I, Kisch E, Isaakov A, Limor R, Baz M, Leshem Y, Flatau E, Miller A, Greenman Y.
Risk factor clustering in hypertensive patients: impact of the reports of NCEP-II and second joint task force on coronary prevention on JNC-VI guidelines.
J Internal Medicine, 248:203-210;2000.
21. Greenman Y, Melmed S.
Thyrotropin-secreting pituitary tumors.
In: Melmed S, ed. The pituitary. Cambridge, Massachusetts: Blackwell Science, Inc; in press, 2001.
22. Ouaknine G, Razon N, Avram J, Veshchev I, Jossipov J, Reider-Grosswasser I, Greenman Y, Tordjman K, Stern N.
Clinically oriented, integrated and programmable classification of pituitary adenomas.
Submitted.
23. Osher E, Greenman Y, Kisch E, Shenkerman G, Koffler M, Shapira I, Stern N.
Attempted lowering of blood pressure to <130/85 mm Hg in type II diabetic hypertensive patients: the diastolic cost.
Submitted.
24. Greenman Y, Veshchev I, Reider I, Segev Y, Ouaknine G, Stern N.
The presence of post-operative sutrasellar remnant is associated with subsequent enlargement of clinically non-functioning pituitary adenomas: a long term follow-up study.
Submitted.
Invited papers in scientific meetings
1. Greenman Y.
Pituitary function tests before and after transpenoidal surgery.
Biannual Conference of the Israel Neurosurgery Society, Israel, June 14, 1990.
2. Greenman Y.
Long-term Follow-up of Nonfunctioning Pituitary Adenomas: Therapeutic Options.
Workshop on pituitary diseases, Israel, March 22, 2001.
3. Greenman Y.
Endocrinological treatment of pituitary tumors.
Clinico-pathological aspects of brain tumors: unsolved issues. A multi-disciplinary approach. Israel, March 25-26, 2001.
Papers presented in scientific meetings
1. Greenman Y, Knoll E, Stern N. Evidence that the renin-angiotensin system modulates renal 12-lipoxygenase activity in man.
18th Annual Aldosterone Conference, San Antonio, TX, June 22-23, 1992.
2. Greenman Y, Razon N, Ouaknine G, Kisch E.
Relative sparing of anterior pituitary function in patients with GH-secreting macroadenomas: comparison with non-functioning adenomas.
9th Israel Medical Week, Jerusalem, Israel, September, 1993.
3. Greenman Y, Melmed S.
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. Symposium on GHRH, GH and IGF-1: Basic and clinical advances. San Diego, CA, December 9-12, 1993.
4. Greenman Y, Melmed S.
Heterogeneous somatostatin receptor expression in pituitary tumors.
76th annual meeting of The Endocrine Society. Anaheim, CA, June 15-18, 1994.
5. Greenman Y, Prager D.
The IGF-1 receptor submembrane domain is intact in GH-secreting pituitary tumors. 76th annual meeting of The Endocrine Society. Anaheim, CA, June15-18, 1994.
6. Greenman Y, Melmed S.
Expression of somatostatin receptor subtype 1 gene transfected in human breast cancer cells and rat pituitary cells.
Western Meeting of the American Federation for Clinical Research, Carmel, CA, February 8-11, 1995.
7. Greenman Y, Woolf P, Coniglio J, O'Mara R, Pei L, Said JW, Melmed S.
Acromegaly caused by a growth hormone-secreting pituitary carcinoma: Biological characterization.
7th Meeting of the European Neuroendocrine Association, Jerusalem, Israel, October 21-24, 1995.
8. Greenman Y, Tordjman K, Trostanetsky Y, Stern N.
Increased body weight associated with prolactin secreting adenomas: weight loss with normalization of prolactin levels.
10th International Congress of Endocrinology, San Francisco, CA, June 12-16, 1996.
9. Trostanetsky Y, Tordjman K, Greenman Y, Stern N.
Increased prevalence of thyroid carcinoma in ”Olim” from the former USSR.
The annual meeting of the Israel Endocrine Society. Tel Aviv, Israel, January 20-23, 1997.
10. Greenman Y, Trostanetsky Y, Tordjman K, Stern N.
Increased prevalence of thyroid carcinoma in immigrants from the former USSR.
79th annual meeting of the Endocrine Society. Minneapolis, USA. June 11-14, 1997.
11. Tordjman K, Greenman Y, Hayat D, Limor R, Ouaknine G, Davidovitch S, Stern N.
The low dose 1 mg-ACTH test predicts intraoperative cortisol response to transphenoidal surgery.
79th annual meeting of the Endocrine Society. Minneapolis, USA. June 11-14, 1997.
12. Stern N, Shapira I, Isakov A, Greenman Y.
Impact of an integrated risk factor control program in post-CABG patients.
1st International Congress on Coronary Artery Disease- from prevention to intervention. Prague, Czech Republic. October 21-24, 1997.
13. Greenman Y, Tordjman K, Somjen D, Reider-Grosswasser I, Kohen F, Ouaknine G, Stern N.
The use of b-subunits of gonadotropin hormones in the follow up of clinically non-functioning pituitary tumors.
The Annual Meeting of the Endocrine Society, 11th Israel Medical Week. Tel Aviv, Israel. December 8-9, 1997.
14. Greenman Y, Tordjman K, Somjen D, Reider-Grosswasser I, Kohen F, Ouaknine G, Stern N.
The use of b-subunits of gonadotropin hormones in the follow up of clinically non-functioning pituitary tumors.
The 80th Annual Meeting of the Endocrine Society. New Orleans, USA. June 24-28, 1998.
15. Stern N, Kisch E, Grosskop I, Greenman Y, Limor R, Miller A, Flatau E, Baz M, Leshem Y, Shapira I.
Risk factor clustering in hypertension: integrating JNC-VI, NCEP II and 1998 Diabetes Expert Committee Reports.
Annual Scientific Meeting of the Israeli Hypertension Association, Herzlia, Israel, October 21, 1998.
16. Greenman Y, Stern N.
Clinical osteoporosis in hypogonadal men with primary empty sella syndrome.
The 81th Annual Meeting of the Endocrine Society, San Diego, USA, June 12-15, 1999.
17. Greenman Y, Veshchev I, Reider I, Ouaknine G, Stern N.
Post-operative management of clinically non-functioning pituitary tumors: is radiation therapy required?
6th International Pituitary Congress, Long Beach, USA, June 15-17, 1999.
18. Greenman Y, Veshchev I, Reider I, Segev Y, Ouaknine G, Stern N.
Post-operative management of clinically non-functioning pituitary tumors: is radiation therapy required?
The annual meeting of the Israel Endocrine Society, Tel Aviv, Israel, November 2-3, 1999.
19. Stern N , Osher E, Baz M , Shenkerman G, Shapira I,. Greenman Y.
Attaining target blood pressure to <130/85 in type II diabetes mellitus: are we ready for the diastolic cost?
5th Scientific Meeting of the Hypertension in Diabetes. Paris, France, May 12-13, 2000.
20. Greenman Y, Trostanetsky Y, Ben-Shemen S, Limor R, Osher E, Lewicka S, Vecsei P, Stern N.
Thyroid Cysts: a new extraadrenal site of aldosterone synthase expression and increased aldosterone content.
26th International Aldosterone Conference, Toronto, Canada, June 19-20, 2000.
21. Greenman Y, Trostanetsky Y, Ben-Shemen S, Limor R, Osher E, Lewicka S, Vecsei P, Stern N.
Thyroid Cysts: a new extraadrenal site of aldosterone synthase expression and increased aldosterone content.
The Endocrine Society 82nd Annual Meeting, Toronto, Canada, June 21-24, 2000.
22. Kabakov E, Greenman Y, Osher E, Baz M, Shenkerman G, Kisch E, Koffler M, Fishel B, Tordjman K, Stern N.
Coronary artery disease in diabetic women: pulse pressure is an important risk factor.
The 18th Meeting of the Israel Diabetes Association, Tel Aviv, Israel, January 31, 2001.
23. Greenman Y, Veshchev I, Reider I, Segev Y, Ouaknine G, Stern N.
The presence of post-operative sutrasellar remnant is associated with subsequent enlargement of clinically non-functioning pituitary adenomas: a long term follow-up study.
The Endocrine Society 83d Annual Meeting, Denver, USA, June 20-23, 2001.
24. Greenman Y, Tordjman K, Flusser G, Stern N.
ACTH-secreting pituitary carcinoma: diagnosis and management.
The Endocrine Society 83d Annual Meeting, Denver, USA, June 20-23, 2001.
25. Greenman Y, Baz M, Veshchev I , Tordjman K, Shenkerman G, Reider I, Ouaknine G, Stern N.
Post-operative treatment of clinically non-functioning pituitary adenomas with bromocriptine decreases the prevalence of tumor remnant growth.
7th International Pituitary Congress, Phoenix, USA, June 23-25, 2001.
|
|
|
|
|
|
|
|
|
 |
